Target intelligence / Profile preview

Multiple immune response pathways

Molecular classification
Other
01

Overview

Multiple immune response pathways refer to the integrated network of biochemical signaling and cellular processes that coordinate the body's defense against exogenous pathogens and endogenous threats like malignant cells. These pathways encompass both the innate immune system, which provides immediate, non-specific defense through mechanisms like Toll-like receptor (TLR) signaling, and the adaptive immune system, which offers highly specific, long-lasting protection via T-cell and B-cell receptor activation (Janeway's Immunobiology, 2016). Key intracellular cascades, including the JAK-STAT, NF-κB, and MAPK pathways, serve as critical hubs that translate external stimuli into gene expression changes and cellular proliferation (Nature Reviews Immunology, 2021). Dysregulation of these pathways is a hallmark of various pathologies, including chronic inflammatory conditions, autoimmune disorders, and the immune evasion seen in cancer (NIH, 2023). Because this term describes a broad set of biological mechanisms rather than a single protein, enzyme, or receptor, it is classified as a descriptive category for therapeutic areas rather than a discrete molecular target.

Other names
Immune system pathwaysImmunological signaling cascadesImmune response mechanismsImmune signaling networks
02

Mechanism of action

Drugs associated with these pathways typically function by modulating specific molecular components—such as cytokines, kinases, or cell-surface receptors—to either suppress pathological immune activation or enhance immune surveillance against pathogens and tumors.

03

Biological functions

Immune responseSignal transductionInflammationAntigen presentationCellular activationCytokine production
04

Disease associations

Autoimmune diseaseInfectionCancerInflammationAllergyImmunodeficiency
05

Safety considerations

Systemic immunosuppressionIncreased susceptibility to opportunistic infectionsCytokine release syndrome (CRS)Autoimmune-related adverse events (irAEs)Impaired wound healing
06

Interacting drugs

5 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Pro-inflammatory cytokines (e.g., IL-6, TNF-alpha)Absolute lymphocyte countErythrocyte sedimentation rate (ESR)Antinuclear antibodies (ANA)

Beyond the preview

Go deeper on Multiple immune response pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple immune response pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call